Safarzadeh Kozani P - Search Results

1

CRISPR/Cas9-medaited knockout of endogenous T-cell receptor in Jurkat cells and generation of NY-ESO-1-specific T cells: An in vitro study.

Safarzadeh Kozani P, Shokrgozar MA, Evazalipour M, Roudkenar MH. Safarzadeh Kozani P, et al. Int Immunopharmacol. 2022 Sep;110:109055. doi: 10.1016/j.intimp.2022.109055. Epub 2022 Jul 16. Int Immunopharmacol. 2022. PMID: 35853277

2

Recent Advances in Solid Tumor CAR-T Cell Therapy: Driving Tumor Cells From Hero to Zero?

Safarzadeh Kozani P, Safarzadeh Kozani P, Ahmadi Najafabadi M, Yousefi F, Mirarefin SMJ, Rahbarizadeh F. Safarzadeh Kozani P, et al. Front Immunol. 2022 May 11;13:795164. doi: 10.3389/fimmu.2022.795164. eCollection 2022. Front Immunol. 2022. PMID: 35634281 Free PMC article. Review.

3

CAR T cells redirected against tumor-specific antigen glycoforms: can low-sugar antigens guarantee a sweet success?

Safarzadeh Kozani P, Safarzadeh Kozani P, Rahbarizadeh F. Safarzadeh Kozani P, et al. Front Med. 2022 Jun;16(3):322-338. doi: 10.1007/s11684-021-0901-2. Epub 2022 Jun 10. Front Med. 2022. PMID: 35687277 Review.

4

Strategies for having a more effective and less toxic CAR T-cell therapy for acute lymphoblastic leukemia.

Hashem Boroojerdi M, Rahbarizadeh F, Safarzadeh Kozani P, Kamali E, Safarzadeh Kozani P. Hashem Boroojerdi M, et al. Among authors: safarzadeh kozani p. Med Oncol. 2020 Oct 12;37(11):100. doi: 10.1007/s12032-020-01416-3. Med Oncol. 2020. PMID: 33047234 Free PMC article. Review.

5

In Like a Lamb; Out Like a Lion: Marching CAR T Cells Toward Enhanced Efficacy in B-ALL.

Safarzadeh Kozani P, Safarzadeh Kozani P, O'Connor RS. Safarzadeh Kozani P, et al. Mol Cancer Ther. 2021 Jul;20(7):1223-1233. doi: 10.1158/1535-7163.MCT-20-1089. Epub 2021 Apr 26. Mol Cancer Ther. 2021. PMID: 33903140 Free PMC article. Review.

6

Addressing the obstacles of CAR T cell migration in solid tumors: wishing a heavy traffic.

Safarzadeh Kozani P, Safarzadeh Kozani P, Rahbarizadeh F. Safarzadeh Kozani P, et al. Crit Rev Biotechnol. 2022 Nov;42(7):1079-1098. doi: 10.1080/07388551.2021.1988509. Epub 2021 Dec 26. Crit Rev Biotechnol. 2022. PMID: 34957875 Review.

7

Nanobody-based CAR-T cells for cancer immunotherapy.

Safarzadeh Kozani P, Naseri A, Mirarefin SMJ, Salem F, Nikbakht M, Evazi Bakhshi S, Safarzadeh Kozani P. Safarzadeh Kozani P, et al. Biomark Res. 2022 Apr 25;10(1):24. doi: 10.1186/s40364-022-00371-7. Biomark Res. 2022. PMID: 35468841 Free PMC article. Review.

8

Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward.

Safarzadeh Kozani P, Safarzadeh Kozani P, Rahbarizadeh F. Safarzadeh Kozani P, et al. Front Immunol. 2021 Oct 28;12:765097. doi: 10.3389/fimmu.2021.765097. eCollection 2021. Front Immunol. 2021. PMID: 34777381 Free PMC article. Review.

9

Directional capacity of human mesenchymal stem cells to support hematopoietic stem cell proliferation in vitro.

Hashem Boroojerdi M, Hosseinpour Sarmadi V, Maqbool M, Ling KH, Safarzadeh Kozani P, Safarzadeh Kozani P, Ramasamy R. Hashem Boroojerdi M, et al. Among authors: safarzadeh kozani p. Gene. 2022 Apr 30;820:146218. doi: 10.1016/j.gene.2022.146218. Epub 2022 Feb 5. Gene. 2022. PMID: 35134469

10

CAR-T cell therapy in T-cell malignancies: Is success a low-hanging fruit?

Safarzadeh Kozani P, Safarzadeh Kozani P, Rahbarizadeh F. Safarzadeh Kozani P, et al. Stem Cell Res Ther. 2021 Oct 7;12(1):527. doi: 10.1186/s13287-021-02595-0. Stem Cell Res Ther. 2021. PMID: 34620233 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters